CC
Chicago Capital Portfolio holdings
AUM $4.05B
1-Year Return
27.64%
This Quarter Return
+3.21%
1 Year Return
+27.64%
3 Year Return
+122.14%
5 Year Return
+196.93%
10 Year Return
–
AUM
$3.36B
AUM Growth
+$82M
(+2.5%)
Cap. Flow
+$80.4M
Cap. Flow
% of AUM
2.39%
Top 10 Holdings %
Top 10 Hldgs %
33.03%
Holding
318
New
25
Increased
113
Reduced
72
Closed
11
Top Buys
| 1 |
Ligand Pharmaceuticals
LGND
|
+$24M |
| 2 |
Burlington
BURL
|
+$17.3M |
| 3 |
Procept Biorobotics
PRCT
|
+$14.2M |
| 4 |
Dell
DELL
|
+$10.5M |
| 5 |
ASML
ASML
|
+$7.84M |
Top Sells
| 1 |
DoubleVerify
DV
|
+$36.7M |
| 2 |
Progressive
PGR
|
+$16.2M |
| 3 |
Teradata
TDC
|
+$14.3M |
| 4 |
Netflix
NFLX
|
+$14.1M |
| 5 |
Thermo Fisher Scientific
TMO
|
+$7.19M |
Sector Composition
| 1 | Technology | 31.06% |
| 2 | Healthcare | 18.24% |
| 3 | Communication Services | 14.08% |
| 4 | Financials | 12.02% |
| 5 | Consumer Discretionary | 8.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
251
monday.com
MNDY
$9.97B
| $364K | 0.01% |
1,510
| – | – |
|
|
WRK
252
DELISTED
WestRock Company
WRK
| $356K | 0.01% |
7,075
| – | – |
|
253
Blackrock
BLK
$173B
| $349K | 0.01% |
443
+106
| +31% | +$83.5K |
|
254
Vanguard Short-Term Corporate Bond ETF
VCSH
$35.5B
| $347K | 0.01% |
4,487
| – | – |
|
255
Corteva
CTVA
$47.6B
| $346K | 0.01% |
6,421
| – | – |
|
256
SPDR Gold Trust
GLD
$116B
| $335K | 0.01% |
1,557
+75
| +5% | +$16.1K |
|
257
Aflac
AFL
$58B
| $333K | 0.01% |
3,728
| – | – |
|
258
OGE Energy
OGE
$8.93B
| $332K | 0.01% |
9,300
| – | – |
|
259
Vanguard Mid-Cap ETF
VO
$87.8B
| $325K | 0.01% |
+1,343
| New | +$325K |
|
260
Norfolk Southern
NSC
$62.2B
| $322K | 0.01% |
1,501
| – | – |
|
261
Enbridge
ENB
$107B
| $319K | 0.01% |
8,965
| – | – |
|
262
General Dynamics
GD
$88B
| $310K | 0.01% |
+1,068
| New | +$310K |
|
263
WEX
WEX
$5.88B
| $306K | 0.01% |
1,728
| – | – |
|
264
Align Technology
ALGN
$9.5B
| $292K | 0.01% |
1,208
| – | – |
|
265
M&T Bank
MTB
$30.7B
| $291K | 0.01% |
1,923
| – | – |
|
266
Motorola Solutions
MSI
$80.4B
| $290K | 0.01% |
752
| – | – |
|
267
Ball Corp
BALL
$13.6B
| $288K | 0.01% |
4,800
| – | – |
|
268
Bio-Techne
TECH
$8.03B
| $287K | 0.01% |
4,000
| – | – |
|
269
Pool Corp
POOL
$12.1B
| $283K | 0.01% |
920
| – | – |
|
270
Novartis
NVS
$239B
| $281K | 0.01% |
2,640
| – | – |
|
271
GSK
GSK
$81.1B
| $281K | 0.01% |
7,287
| – | – |
|
272
CME Group
CME
$93.3B
| $280K | 0.01% |
1,423
| – | – |
|
273
Gilead Sciences
GILD
$140B
| $280K | 0.01% |
4,074
-220
| -5% | -$15.1K |
|
274
Atlassian
TEAM
$45.6B
| $275K | 0.01% |
1,555
| – | – |
|
275
IQVIA
IQV
$31.6B
| $275K | 0.01% |
1,300
| – | – |
|